NEwsletters
January 2024
Dr. Avirup Bose has joined the Iktos team as the new Chief Business Officer. Prior to joining Iktos, Avirup was Vice President and Head of Business Development at…Read more
October 2023
We are thrilled to announce that Iktos has won the “Big Data & AI for Good” prize at the 12th edition of the Big Data & AI Paris Congress on 25th September. We are very honoured …Read more
July 2023
Interested in learning about Generative AI for de novo drug design? Iktos hosted a webinar on ‘Where do we start if we don’t have any data? AI for early-stage projects …Read more
April 2023
Iktos announces the closing of a € 15.5m Series A financing to expand its artificial intelligence-based drug discovery technologies …Read more
January 2023
Peptides are a promising class of therapeutics with unique properties. They share some advantages of proteins, such as their …Read more
October 2022
Our CSO, Dr. Quentin Perron and VP, Head of BD- EU, RoW Dr. Sree Vadlamudi presented a webinar on ‘Makya™ …Read more
August 2022
Take a tour of our new website and explore our AI-driven generative modeling technology platform …Read more
April 2022
We are very pleased to announce our 2nd Annual ‘AI for De Novo Drug Design’ Conference to be held virtually on May 3 and 4, 2022…Read more
January 2022
Our research paper on ‘Integrating synthetic accessibility with AI-based generative drug design’ was recently published by ChemRxiv…Read more
October 2021
We presented a webinar on ‘Spaya: Artificial Intelligence to discover and prioritise synthetic routes’. If you missed…Read more